Latest General Interest Stories

ArticlesDrug Discovery and DevelopmentFeatured StoriesGeneral Interest

Understanding Biomarkers for Better Drug Discovery and Development

Biomarker intelligence comes from understanding the biomarker landscape, that is, the characteristics and features of biomarkers, and disease pathways. This understanding, in turn, helps to recognize the utility of biomarkers. In this study, we partnered with Amplion Inc., to investigate biomarker usage in 24 immunotherapy companies. We found the most popular biomarkers and learnt how they are being used by each company.
READ MORE →
ArticlesDrug Discovery and DevelopmentFeatured StoriesGeneral Interest

Biosimilars. Are They Ready for Primetime?

Is the hype surrounding biosimilars real or simply a hopeful view on an exceedingly expensive drug market? Read this article to find out more about biosimilars and understand the challenges facing the biosimilars industry.
READ MORE →

More General Interest Stories